|
|
|
|
Vol. 10, Issue 12, 4441-4450, December 1999


*Diabetes Branch, National Institute of Diabetes and Digestive and
Kidney Diseases, Bethesda, Maryland 20892-1770; and
Previous studies have found conflicting associations between
susceptibility to activation-induced cell death and the cell cycle in T
cells. However, most of the studies used potentially toxic
pharmacological agents for cell cycle synchronization. A panel of human
melanoma tumor-reactive T cell lines, a CD8+ HER-2/neu-reactive T cell
clone, and the leukemic T cell line Jurkat were separated by
centrifugal elutriation. Fractions enriched for the G0-G1, S, and
G2-M phases of the cell cycle were assayed for T cell
receptor-mediated activation as measured by intracellular
Ca2+ flux, cytolytic recognition of tumor targets, and
induction of Fas ligand mRNA. Susceptibility to apoptosis induced by
recombinant Fas ligand and activation-induced cell death were
also studied. None of the parameters studied was specific to a certain
phase of the cell cycle, leading us to conclude that in nontransformed human T cells, both activation and apoptosis through T cell receptor activation can occur in all phases of the cell cycle.
Surgery Branch, National Cancer Institute, Bethesda,
Maryland 20892-1502
Corresponding author. E-mail address:
karas{at}box-k.nih.gov.
This article has been cited by other articles:
![]() |
N. Marzo, S. Ortega, T. Stratmann, A. Garcia, M. Rios, A. Gimenez, R. Gomis, and C. Mora Cyclin-Dependent Kinase 4 Hyperactivity Promotes Autoreactivity in the Immune System but Protects Pancreatic Cell Mass from Autoimmune Destruction in the Nonobese Diabetic Mouse Model J. Immunol., January 15, 2008; 180(2): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Torgler, S. Jakob, E. Ontsouka, U. Nachbur, C. Mueller, D. R. Green, and T. Brunner Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex J. Biol. Chem., September 3, 2004; 279(36): 37334 - 37342. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoshima, M. Karas, S. Yakar, J. Dupont, Lee Helman, and D. LeRoith TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival J. Biol. Chem., June 11, 2004; 279(24): 25898 - 25904. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Green and D. G. Rowbottom Exercise-induced changes to in vitro T-lymphocyte mitogen responses using CFSE J Appl Physiol, July 1, 2003; 95(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Berger, D. Hanlon, D. Kanada, M. Dhodapkar, V. Lombillo, N. Wang, I. Christensen, G. Howe, J. Crouch, P. El-Fishawy, et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells Blood, April 15, 2002; 99(8): 2929 - 2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Vallejo, M. Schirmer, C. M. Weyand, and J. J. Goronzy Clonality and Longevity of CD4+CD28null T Cells Are Associated with Defects in Apoptotic Pathways J. Immunol., December 1, 2000; 165(11): 6301 - 6307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dupont, A. M. Fernandez, C. A. Glackin, L. Helman, and D. LeRoith Insulin-like Growth Factor 1 (IGF-1)-induced Twist Expression Is Involved in the Anti-apoptotic Effects of the IGF-1 Receptor J. Biol. Chem., July 6, 2001; 276(28): 26699 - 26707. [Abstract] [Full Text] [PDF] |
||||